Gerry Connolly

As soon as he got out of the hearing, you know what he called us? Imbeciles.

I begged Martin Shkreli to use whatever influence he still had over his company to lower their prices.

While the price of EpiPens shot up exponentially, so did Ms. Bresch's paycheck and the lavish compensation of her fellow executives at Mylan.

You have 94 percent of the market share.

I don't care what your profit is. I mean, America is built on profits. Profits are an incentive.

So what happened between 2007 and 2016 different than the previous manufacturer and producer?

I was just struck with what humanitarians you people of Mylan really are.

They raised the prices, the reason being, I believe, to get filthy rich at the expense of our constituents.

I did read your testimony, Ms. Bresch, and I was not impressed.

I'm concerned that this is a rope-a-dope strategy.

Mylan has received more than $4 billion in net sales revenue on this one drug over the last decade.

The burden is on the Government of Turkey to present evidence that would meet any reasonable legal threshold.

I share the concern of the chairman and my colleagues that President Erdogan... has actually lost sympathy.

I happen to believe that the U.S.-Turkey relationship is a very strategic and critical one.

This money was a payment for undelivered Iranian-owned, American-made military equipment dating back before the 1979 Islamic Revolution.

The point you are making about ransom, do I understand the point you are making is that when you have used such a highly-charged emotive word, you have clearly prejudged the situation.

I strongly support Mr. Engel's amendment, which I think accomplishes what all of us on this committee in a bipartisan way should want.

The Iran nuclear deal is working. Natanz--Iran has put 19,000 centrifuges in storage under international control. That is a win.

I believe that Mr. Engel has made a very creative attempt at trying to find common ground. I will support Mr. Engel's substitute, and, sadly, I will be required to oppose the chairman's bill.

If we are serious about this legislation, let's have a hearing. Let's hear from the State Department and others in the administration to explain the thinking behind the decisions that were made.

I would like to see our committee try to act, on controversial issues especially, in the bipartisan manner that, by and large, has characterized, I think, your chairmanship and the ranking member's tenure as well.

Could my friend speculate that it might have something to do with the fact that we are less than 60 days away from the presidential election?

We have had no testimony, no witnesses, no hearings or anything of that nature, so it looks that this is a political bill.

Until recently, Moshe Ya'alon was the Israeli Defense Minister. He said, today, because of the nuclear deal, Iran no longer poses an existential threat to Israel.

I don't think we have--I mean, it is not apparent to me that we have a lot of options.